PHAT Q2 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$149,000

Operating Income

-$45M

Net Income

-$51M

EPS (Diluted)

$-1.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$214M

Total Liabilities

$221M

Stockholders' Equity

-$7M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$149,000	-$131,000	-13.7%
Operating Income	-$45M	-$35M	-28.4%
Net Income	-$51M	-$37M	-39.3%